Liu Y, Jiao C, Zhang T, Li X, Li P, Lu M, et al
Always consult a licensed healthcare provider before beginning any new injection, infusion or supplement program, especially if you have underlying health conditions or take prescription medications
However, the exact order, timing and coordination of these modifications in mammalian cells remain incompletely defined
The SURMOUNT-1 trial specifically noted that participants with a BMI of 35 or higher who received the 15mg tirzepatide dose lost an average of 26.5% of their body weight, substantially higher than the overall trial average
Potential for personalized obesity therapies using AI-driven patient profiling and biomarker analysis
The GLP-1 market is projected to reach $578.9M by 2030, growing at a 27.5% CAGR a massive opportunity for Indias health and pharma sectors